WHO Issues Concern Over Severe Shortage of Obesity Jabs
Less than a tenth of patients who could benefit from GLP-1 drugs including Wegovy can access them, states the World Health Organization as it publishes its first guidance on the medications.
Considering in excess of 1,000,000,000 people worldwide now classified as obese, it is calling for more widespread and fairer access to these injectable treatments.
Per forecasts, more than two billion will be living with obesity by 2030 without intervention.
"Our latest guidance acknowledges that excess weight is a chronic disease that can be treated with comprehensive and continuous care," said its chief Tedros Adhanom Ghebreyesus.
Substantial prices, limited production capacity, and distribution challenges are major barriers to broad availability to the injections that can aid individuals in losing considerable body mass, notes the body.
Skinny Jab Supply Crisis
Even in the present most favorable case, the production of these medications would only suffice for about 100 million people – less than 10% of the global need, per the health organization.
The recommendation encourages nations and manufacturers to widen availability, via measures including patent sharing.
The intellectual property rights on a key compound – the primary ingredient of Novo Nordisk's Wegovy – is set to lapse in multiple countries in 2026.
The Way Weight-Loss Drugs Operate
These medications replicate a natural hormone to reduce digestion speed, reduce hunger and boost satiety so people eat less.
People usually see weight reduction in the initial weeks of starting on the regular doses.
Studies suggests patients may regain a significant portion a year later of halting the treatment, because their usual hunger come back.
Being carrying excess weight raises your likelihood for developing health problems, like type 2 diabetes, cardiovascular issues, brain attack, and specific cancers.
Obesity concerns individuals in countries worldwide and was linked to 3.7 million fatalities worldwide in 2024, per the health agency.
